Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Roseline Tang"'
Autor:
Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, Etienne Rouleau, Alexandra Leary
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-9 (2023)
Abstract Background Knowing the homologous recombination deficiency (HRD) status in advanced epithelial ovarian cancer (EOC) is vital for patient management. HRD is determined by BRCA1/BRCA2 pathogenic variants or genomic instability. However, tumor
Externí odkaz:
https://doaj.org/article/16f627eaf07e4fe8ab803da24e0b8223
Autor:
Maria Kfoury, Reda El Hazzaz, Claire Sanson, Felix Blanc Durand, Judith Michels, Emeline Colomba Blameble, Roseline Tang, Audrey Le Formal, Elodie Lecerf, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Etienne Rouleau, Alexandra Leary
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-4 (2023)
Abstract Genomic testing is crucial for the management of ovarian cancer. DNA from biopsies at diagnostic laparoscopies or interval debulking surgery after neoadjuvant chemotherapy, has a high failure rate. At relapse, biopsies may not be feasible. T
Externí odkaz:
https://doaj.org/article/0723fed9251a4a12938d6a742423f645
Autor:
Félix Blanc-Durand, Roseline Tang, Margaux Pommier, Marzieh Nashvi, Sophie Cotteret, Catherine Genestie, Audrey Le Formal, Patricia Pautier, Judith Michels, Maria Kfoury, Robert Hervé, Sylvie Mengue, Estelle Wafo, Antoine Elies, Gregoire Miailhe, Jennifer Uzan, Etienne Rouleau, Alexandra Leary
Publikováno v:
Clinical Cancer Research. :OF1-OF6
Purpose: Homologous recombination deficiency (HRD) is closely related to PARP inhibitor (PARPi) benefit in ovarian cancer. The capacity of BRCA1 promoter methylation to predict prognosis and HRD status remains unclear. We aimed to correlate BRCA1 pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3b3818fdcf9f022a8c524214ee86c29
https://doi.org/10.1158/1078-0432.ccr-22-3328
https://doi.org/10.1158/1078-0432.ccr-22-3328
Autor:
Raphaël Leman, Étienne Muller, Nicolas Goardon, Imène Chentli, Aurore Tranchant, Angelina Legros, Laurent Castera, Florence Joly, Alain Morel, Christel Brunet, Véronique Bocly, Éric Fernandez, Florence Coulet, Roseline Tang, Étienne Rouleau, Florine Oca, Romain Boucly, Aurélie Dumont, Catherine Genestie, Hans-Joachim Lück, Piera Gargiulo, Diana Bello Roufai, Marie-Ange Mouret-Reynier, Hugues Bourgeois, Anne-Claire Hardy-Bessard, Christine Montoto, Isabelle Ray-Coquard, Éric Pujade-Lauraine, Dominique Vaur
Publikováno v:
Innovations & Thérapeutiques en Oncologie. 9:31-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25a35d47f5ee5e83f4fbc2f7e2e717e6
https://doi.org/10.1684/ito.2023.0362
https://doi.org/10.1684/ito.2023.0362
Autor:
Alexandra Leary, Etienne Rouleau, Jennifer Uzan, Gregoire Miailhe, Antoine Elies, Estelle Wafo, Sylvie Mengue, Robert Hervé, Maria Kfoury, Judith Michels, Patricia Pautier, Audrey Le Formal, Catherine Genestie, Sophie Cotteret, Marzieh Nashvi, Margaux Pommier, Roseline Tang, Félix Blanc-Durand
Clinical data and outcomes of patients included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::069e168eebd509d26b467df252f13715
https://doi.org/10.1158/1078-0432.22734085
https://doi.org/10.1158/1078-0432.22734085
Autor:
Alexandra Leary, Etienne Rouleau, Jennifer Uzan, Gregoire Miailhe, Antoine Elies, Estelle Wafo, Sylvie Mengue, Robert Hervé, Maria Kfoury, Judith Michels, Patricia Pautier, Audrey Le Formal, Catherine Genestie, Sophie Cotteret, Marzieh Nashvi, Margaux Pommier, Roseline Tang, Félix Blanc-Durand
Purpose:Homologous recombination deficiency (HRD) is closely related to PARP inhibitor (PARPi) benefit in ovarian cancer. The capacity of BRCA1 promoter methylation to predict prognosis and HRD status remains unclear. We aimed to correlate BRCA1 prom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73068a1a9e267ca8617cf51b8e4abbf9
https://doi.org/10.1158/1078-0432.c.6626956.v1
https://doi.org/10.1158/1078-0432.c.6626956.v1
Autor:
Jihenne, Ben Aissa-Haj, Hugo, Pinheiro, François, Cornelis, Molka, Sebai, Didier, Meseure, Adrien, Briaux, Philippe, Berteaux, Cedric, Lefol, Gaëtan, Des Guetz, Martine, Trassard, Denise, Stevens, François, Vialard, Ivan, Bieche, Catherine, Noguès, Roseline, Tang, Carla, Oliveira, Dominique, Stoppat-Lyonnet, Rosette, Lidereau, Etienne, Rouleau
Publikováno v:
Genes. 13(12)
E-cadherin, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b3b720fa30330973bd31292688142cf
https://pubmed.ncbi.nlm.nih.gov/36553480
https://pubmed.ncbi.nlm.nih.gov/36553480
Autor:
Cyril Roussel-Simonin, Felix Blanc-Durand, Etienne Roueau, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sebastien Gouy, Amandine Maulard, Stéphanie Cherrier, Claire Sanson, Lea Mauny, Sophie Coterret, Francois Zaccarini, Roseline Tang, Alexandra Leary
Publikováno v:
Cancer Research. 83:3368-3368
Background: Knowledge regarding the homologous recombination deficiency (HRD) status at diagnosis is essential to manage patients (pts) with advanced epithelial ovarian cancer (EOC). HRD is defined by either a BRCA1 or BRCA2 mutation, or genomic inst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbf3d02a0de3b87d015fb2b8fe59548e
https://doi.org/10.1158/1538-7445.am2023-3368
https://doi.org/10.1158/1538-7445.am2023-3368
Autor:
Roseline Tang, Sophie Cotteret, Jean Pegliasco, Christine Bellanné-Chantelot, Véronique Saada, Clemence Legoupil, Olivier Caron, Pascal Fuseau, Adel Ben-Ali, Pascale Cornillet-Lefebvre, Raouf Benabelali, Stéphane de Botton, Jean-Henri Bourhis, Christophe Marzac, Jean-Edouard Martin, Jean-Baptiste Micol, Nathalie Auger, William Vainchenker, Isabelle Plo, Florence Pasquier, Jean-Côme Meniane, Jacques Delaunay, Christophe Willekens, Maureen Lopez, Samy Chraibi, Odile Bera, Philippe Helias, Barbara Panneau-Schmaltz, Christian Recher
Publikováno v:
Blood. 132:1482-1482
In 2015, a germline copy number variation of chromosome 14 (CNVdup14) including ATG2B and GSKIP genes was described as a predisposition genetic factor responsible of familial myeloproliferative neoplasms from French West Indies (Saliba et al, Nat Gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee39f11ce153b504f87f9b982ee9f732
https://doi.org/10.1182/blood-2018-99-110366
https://doi.org/10.1182/blood-2018-99-110366